Correlation Between Eyepoint Pharmaceuticals and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eyepoint Pharmaceuticals and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyepoint Pharmaceuticals and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyepoint Pharmaceuticals and Transcode Therapeutics, you can compare the effects of market volatilities on Eyepoint Pharmaceuticals and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyepoint Pharmaceuticals with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyepoint Pharmaceuticals and Transcode Therapeutics.
Diversification Opportunities for Eyepoint Pharmaceuticals and Transcode Therapeutics
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Eyepoint and Transcode is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Eyepoint Pharmaceuticals and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Eyepoint Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyepoint Pharmaceuticals are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Eyepoint Pharmaceuticals i.e., Eyepoint Pharmaceuticals and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Eyepoint Pharmaceuticals and Transcode Therapeutics
Given the investment horizon of 90 days Eyepoint Pharmaceuticals is expected to under-perform the Transcode Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Eyepoint Pharmaceuticals is 1.34 times less risky than Transcode Therapeutics. The stock trades about -0.25 of its potential returns per unit of risk. The Transcode Therapeutics is currently generating about -0.18 of returns per unit of risk over similar time horizon. If you would invest 47.00 in Transcode Therapeutics on September 1, 2024 and sell it today you would lose (12.00) from holding Transcode Therapeutics or give up 25.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eyepoint Pharmaceuticals vs. Transcode Therapeutics
Performance |
| Timeline |
| Eyepoint Pharmaceuticals |
| Transcode Therapeutics |
Eyepoint Pharmaceuticals and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eyepoint Pharmaceuticals and Transcode Therapeutics
The main advantage of trading using opposite Eyepoint Pharmaceuticals and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyepoint Pharmaceuticals position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.The idea behind Eyepoint Pharmaceuticals and Transcode Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Transcode Therapeutics vs. Tff Pharmaceuticals | Transcode Therapeutics vs. Eliem Therapeutics | Transcode Therapeutics vs. Inhibrx | Transcode Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |